These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1723065)

  • 1. T-cell clones identify three distinct epitopes associated with HLA-Dw14.
    Mickelson EM; Masewicz S; Smith A; Petersdorf E; Nepom GT; Martin PJ; Hansen JA
    Hum Immunol; 1991 Nov; 32(3):229-33. PubMed ID: 1723065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of class II beta-chain amino acid residues 85 and 86 in T-cell allorecognition.
    Eckels DD; Geiger MJ; Sell TW; Gorski JA
    Hum Immunol; 1990 Mar; 27(3):240-53. PubMed ID: 1692822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shared T cell recognition sites on human histocompatibility leukocyte antigen class II molecules of patients with seropositive rheumatoid arthritis.
    Goronzy J; Weyand CM; Fathman CG
    J Clin Invest; 1986 Mar; 77(3):1042-9. PubMed ID: 2419361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T-cell clones used to define functional epitopes on HLA class II molecules.
    Weyand CM; Goronzy J; Fathman CG
    Proc Natl Acad Sci U S A; 1986 Feb; 83(3):762-6. PubMed ID: 2418442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-Dw14 and HLA-DR3 haplotypes share a functional determinant recognized by a human alloreactive T-cell clone.
    Lang B; LoGalbo PR; Sanchez B; Winchester R
    Hum Immunol; 1988 Sep; 23(1):59-70. PubMed ID: 2461353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A specific nucleotide sequence defines a functional T-cell recognition epitope shared by diverse HLA-DR specificities.
    Seyfried CE; Mickelson E; Hansen JA; Nepom GT
    Hum Immunol; 1988 Apr; 21(4):289-99. PubMed ID: 2453493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonrandom selection of T cell specificities in anti-HLA-DR responses. Sequence motifs of the responder HLA-DR allele influence T cell recruitment.
    Weyand CM; Hicok KC; Goronzy JJ
    J Immunol; 1991 Jul; 147(1):70-8. PubMed ID: 2051028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell receptor V beta selectivity in T-cell clones alloreactive to HLA-Dw14.
    Yamanaka K; Kwok WW; Mickelson EM; Masewicz S; Nepom GT
    Hum Immunol; 1992 Jan; 33(1):57-64. PubMed ID: 1532170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural model for T-cell recognition of HLA class II-associated alloepitopes.
    Reinsmoen NL; Bach FH
    Hum Immunol; 1990 Jan; 27(1):51-72. PubMed ID: 1689285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different regions of the N-terminal domains of HLA-DR1 influence recognition of individual peptide-DR1 complexes.
    Tuosto L; Karr RW; Fu XT; Olson RR; Cundari E; Piccolella E; Lechler R; Lombardi G
    Hum Immunol; 1994 Aug; 40(4):312-22. PubMed ID: 7528190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of peptide-dependent allospecific epitopes on HLA-DR4 molecules by HLA-DM.
    Drover S; Kovats S; Masewicz S; Blum JS; Nepom GT
    Hum Immunol; 1998 Feb; 59(2):77-86. PubMed ID: 9536430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloreactive T cells can distinguish between the same human class II MHC products on different B cell lines.
    Santamaria P; Boyce-Jacino MT; Lindstrom AL; Rich SS; Faras AJ; Barbosa JJ
    J Immunol; 1991 Mar; 146(6):1822-8. PubMed ID: 1706381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DQw3 variants defined by cloned alloreactive T cells.
    Mickelson EM; Nepom GT; Nisperos B; Hansen JA
    Hum Immunol; 1988 Jan; 21(1):63-73. PubMed ID: 2452816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared molecular markers of genetic predisposition to seropositive rheumatoid arthritis.
    Morel PA; Horn GT; Budd RC; Erlich HA; Fathman CG
    Hum Immunol; 1990 Feb; 27(2):90-9. PubMed ID: 2298612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of T-cell receptor-contacting and peptide-binding residues of the class II molecule HLA-DR4 Dw10 to serologic and antigen-specific T-cell recognition.
    Barber LD; Bal V; Lamb JR; O'Hehir RE; Yendle J; Hancock RJ; Lechler RI
    Hum Immunol; 1991 Oct; 32(2):110-8. PubMed ID: 1744001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
    Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
    J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal analysis of HLA-DR and -DQ associated determinants: their contribution to Dw specificities.
    Reinsmoen NL; Bach FH
    Hum Immunol; 1986 Aug; 16(4):329-46. PubMed ID: 2428780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further DNA sequence microheterogeneity of the HLA-DR4/Dw13 haplotype group: importance of amino acid position 86 of the DR beta 1 chain for T-cell recognition.
    Lang B; Navarrete C; LoGalbo PR; Nepom GT; Silver J; Winchester RJ; Gregersen PK
    Hum Immunol; 1990 Apr; 27(4):378-89. PubMed ID: 1690694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple epitopes of HLA-DRB1*0411 are recognized by T-cell clones originated from individuals carrying other DR4 subtypes.
    Araujo HA; Dole K; Lazaro AM; Fernandez-Vina M; Stastny P
    Hum Immunol; 1998 Sep; 59(9):561-70. PubMed ID: 9757912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dw subtypes of serologically defined DR-DQ specificities restrict recognition of cytomegalovirus.
    Linner KM; Monroy C; Bach FH; Gehrz RC
    Hum Immunol; 1986 Oct; 17(2):79-86. PubMed ID: 2428785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.